Cambridge Research Biochemicals Launches Second Catalogue To The Life Science Community

By Bio-IT World Staff 

February 21, 2017 | Cambridge Research Biochemicals (CRB) today announced the release of its new DISCOVERY Antibodies catalogue. The new product range will offer the same high quality antibodies that CRB is famed for and includes sought-after targets suggested by revered customers in addition to complex, rare and post translational modification specific custom-made antibodies. Each month, new product lines are being added to supplement the selection in place and antigen peptides synthesized in-house are also available to purchase, offering an extra validation method for the customer and differentiating CRB from other Catalogue Antibody providers.

Since CRB's expansion and relocation, the capacity for production has increased substantially, meaning that the custom side of CRB's business will continue whilst the new catalogue is developed. In addition to the brand new DISCOVERY Antibodies website, complete with e-commerce functionalities, detailed product descriptions and comprehensive analytical data, CRB is also having its existing website redesigned to improve user experience, a project which is now nearing completion. 

CRB also launched DISCOVERY Peptides, the peptides counterpart to DISCOVERY Antibodies in 2016 - the site already features a selection of popular peptide candidates all synthesized at CRB’s Teesside premises.